[Therapeutic strategy in asthma: special cases and pseudo-asthma].
Therapeutic strategy of asthma such as that described by international consensus must sometimes be modified in certain situations, the triggering agent or subsequent complications. Account should also be taken of pseudo-asthmas, i.e. other illnesses accompanying the sibilant dyspnoea. The therapeutic principles of each of these conditions are set out and specially emphasize asthma in pregnancy and states of resistance to corticosteroids.
Radermecker
M
M
Service de Pneumologie, CHU Sart Tilman, Université de Liège, Belgique.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D001249:Asthma / Q000150:complications / Q000209:etiology / Q000628:therapy*; D001250:Asthma, Exercise-Induced / Q000503:physiopathology / Q000628:therapy; D002319:Cardiovascular System / Q000503:physiopathology; D005260:Female; D006801:Humans; D006985:Hyperventilation / Q000175:diagnosis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D012119:Respiration; D014826:Vocal Cord Paralysis / Q000175:diagnosis
D000319:Adrenergic beta-Antagonists; D001241:Aspirin
Stratégie thérapeutique dans l'asthme: cas particuliers et pseudo-asthmes.